The Clinical Application of Infrared Thermal Imaging Detecting Venous Thromboembolism
NCT ID: NCT02552420
Last Updated: 2015-09-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
128 participants
OBSERVATIONAL
2007-09-30
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound Assessment of Isolated Distal Deep Vein Thrombosis
NCT06596941
Diagnostic and Prognostic Prediction Models for Chinese Patients With Venous Thromboembolism
NCT03802929
Simplification of the Diagnosis of Deep Vein Thrombosis
NCT01412242
Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis
NCT02414802
Venous Thromboembolism (VTE) Knowledge
NCT05548010
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Aged: 18-75 years. They had been definitively diagnosed with venous thromboembolism,
3. The bed-rest immobilization time should be more than 72 hours,
4. Planing to gynecology operation,
5. The D dimer should be more than500 g • L-1,
6. There is no obvious symptoms of systemic infection two weeks before the test,
7. There is no trauma, infection, biopsy or puncture, hemorrhage and tumor in the corresponding detection site (chest and lower limbs),
8. There is no skin disease, heart, liver, kidney, gastrointestinal tract, hematopoietic system and mental, neurological has no serious diseases.
Exclusion Criteria
2. Doctors believe that there is any inappropriate situations.
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The First Affiliated Hospital of Guangzhou Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fangge Deng
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GIRD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.